Sign In
Buy ATRA
$9.63
-0.270 (-2.73%)
At Close: Jun 03, 2026
William Blair Remains a Buy on Incyte (INCY)
04:06pm, Friday, 24'th Apr 2020
In a report issued on April 20, Matt Phipps from William Blair maintained a Buy rating on Incyte (INCY). The company's shares closed last Friday at
William Blair Remains a Buy on Incyte (INCY)
04:06pm, Friday, 24'th Apr 2020
In a report issued on April 20, Matt Phipps from William Blair maintained a Buy rating on Incyte (INCY –
Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Zogenix (ZGNX)
04:06pm, Friday, 24'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB) and Zogenix (ZGNX). Biogen (BIIB) In a report issued on
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (NASDAQ: BIIB) and Zogenix (NASDAQ: ZGNX)
04:06pm, Friday, 24'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (
BIIB
–
Research Report
) and Zogenix (
ZGNX
–
Research Report
).
Biogen (BIIB)
In a report issued on Apri
Gilead Sciences (GILD) Receives a Buy from Mizuho Securities
06:07pm, Thursday, 23'rd Apr 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences (GILD) today and set a price target of $81.00. The company's shares closed
Gilead Sciences (GILD) Receives a Buy from Mizuho Securities
06:07pm, Thursday, 23'rd Apr 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a
Two shops cut views on Biogen as hopes for Alzheimer's med fade
11:13am, Thursday, 23'rd Apr 2020
Athersys (NASDAQ:ATHX) initiated with an Outperform rating and a $14 (528% upside) price target at SMBC Nikko.Livongo Health (NASDAQ:LVGO) initiated with a Buy rating and a $46 (22% upside) price targ
Atara Biotherapeutics upgraded to Buy on valuation at Citi ATRA
10:46am, Thursday, 23'rd Apr 2020
Atara Biotherapeutics upgraded to Buy on valuation at Citi Citi ATRA
Analysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Aileron Therapeutics (ALRN)
10:05am, Thursday, 23'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tactile Systems Technology (TCMD) and Aileron Therapeutics
Analysts Offer Insights on Healthcare Companies: Tactile Systems Technology (NASDAQ: TCMD) and Aileron Therapeutics (NASDAQ: ALRN)
10:05am, Thursday, 23'rd Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tactile Systems Technology (
TCMD
–
Research Report
) and Aileron Therapeutics (
ALRN
–
Research Re
Atara Biotherapeutics upgraded to Buy from Neutral at Citi ATRA
09:03am, Thursday, 23'rd Apr 2020
Atara Biotherapeutics upgraded to Buy from Neutral at Citi Citi ATRA
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
12:30am, Thursday, 23'rd Apr 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today
Atara Biotherapeutics shares are trading higher after Citigroup upgraded the stock from Neutral to Buy.
12:00am, Thursday, 23'rd Apr 2020Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Medtronic (MDT)
12:05pm, Wednesday, 22'nd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB) and Medtronic (MDT). Biogen (BIIB) Mizuho Securities
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Medtronic (NYSE: MDT)
12:05pm, Wednesday, 22'nd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (
BIIB
–
Research Report
) and Medtronic (
MDT
–
Research Report
).
Biogen (BIIB)
Mizuho Securities analyst
